Genetic susceptibility to eating disorders: associated polymorphisms and pharmacogenetic suggestions.
about
Eating disorders in womenIdentification of hypothalamic neuron-derived neurotrophic factor as a novel factor modulating appetiteConceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa.The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.The 5-HTTLPR confers susceptibility to anorexia nervosa in Han Chinese: evidence from a case-control and family-based study.Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in miceAre obesity risk genes associated with binge eating in adolescence?Contemporary views on the genetics of anorexia nervosa.The 5-HTTLPR polymorphism and eating disorders: a meta-analysis.Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials.Discussing the putative role of obesity-associated genes in the etiopathogenesis of eating disorders.Prospects of psychosomatic medicine.BDNF genetic variability modulates psychopathological symptoms in patients with eating disorders.Development of a new genotyping assay for detection of the BDNF Val66Met polymorphism using melting-curve analysis.Genetics of Anorexia Nervosa.Impact of NEGR1 genetic variability on psychological traits of patients with eating disorders.Association between serotonin transporter gene polymorphism and eating disorders outcome: a 6-year follow-up study.
P2860
Q26795399-808CC372-47C0-4B33-8E24-D4981D7A05E0Q28592871-3D9AAA2F-701F-4A7E-A4C9-92F69D438EF0Q34020568-FA6B49F7-9454-49C5-953D-29E86D0474C5Q34469404-238A903C-1DE7-440B-A419-95391419C864Q35192252-1566A531-BD1D-49C6-BADE-1D5783A5C816Q35982317-8B239464-A7B9-49E0-B298-15F5C27AF4B0Q36320954-B55E260F-77B0-4815-B18E-0AA924699766Q36711856-D5AB8DFD-E1C3-438B-900E-A041E24D0C18Q37704258-9580E6F7-F660-4BFD-8AC9-B3C1FBE44CB6Q38013059-4B6190F9-D856-4C5D-A51D-2455583E7993Q38565091-7F318C33-83FC-4D7A-8320-64EE644436A1Q43180634-61E95C9F-F684-4959-9DFF-1D3BE4D5F911Q44330054-F2228D4F-2C84-454E-B12A-42F5F2D0B8E8Q45418747-6F0802CB-1FD4-4581-B3CE-0694A5586776Q47933638-BD60856E-5618-4E52-8152-D354C46AF835Q48524901-61BE1D98-A48D-40AE-BCB6-BA7B4307BE92Q48701592-146C8F7A-DB1C-4725-80E3-3BC4615BE197
P2860
Genetic susceptibility to eating disorders: associated polymorphisms and pharmacogenetic suggestions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic susceptibility to eati ...... d pharmacogenetic suggestions.
@en
Genetic susceptibility to eati ...... d pharmacogenetic suggestions.
@nl
type
label
Genetic susceptibility to eati ...... d pharmacogenetic suggestions.
@en
Genetic susceptibility to eati ...... d pharmacogenetic suggestions.
@nl
prefLabel
Genetic susceptibility to eati ...... d pharmacogenetic suggestions.
@en
Genetic susceptibility to eati ...... d pharmacogenetic suggestions.
@nl
P2860
P1433
P1476
Genetic susceptibility to eati ...... d pharmacogenetic suggestions.
@en
P2093
Palmiero Monteleone
P2860
P304
P356
10.2217/14622416.9.10.1487
P577
2008-10-01T00:00:00Z